Safety Data. lcagen has disclosed to Roche and will promptly (in compliance with Applicable Law) continue to disclose to Roche (i) the results of all preclinical testing and human clinical testing of Product in its possession or Control and (ii) all information in its possession or Control concerning side effects, injury, toxicity or sensitivity reaction and incidents or severity thereof with respect to Product.
Appears in 3 contracts
Sources: License Agreement (Avista Public Acquisition Corp. II), License Agreement (Avista Public Acquisition Corp. II), License Agreement (OmniAb, Inc.)